Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Journal De La Societe De Biologie|July 27, 2007
[Directed molecular evolution of antibodies]Olivier Dubreuil, Bruno Muller, Marc Bossus, et al.Journal of Molecular Biology|November 2, 2010
Fab'-induced folding of antigenic N-terminal peptides from intrinsically disordered HIV-1 Tat revealed by X-ray crystallographyJennifer Serrière, Jean-Marc Dugua, Marc Bossus, et al.Journal of Molecular Biology|November 1, 2011
Crystal structure of human prostate-specific antigen in a sandwich antibody complexEnrico A Stura, Bruno H Muller, Marc Bossus, et al.Journal of Molecular Biology|January 12, 2008
Crystal structure of a ternary complex between human prostate-specific antigen, its substrate acyl intermediate and an activating antibodyRenée Ménez, Sandrine Michel, Bruno H Muller, et al.The Journal of Biological Chemistry|May 10, 2005
Fine tuning of the specificity of an anti-progesterone antibody by first and second sphere residue engineeringOlivier Dubreuil, Marc Bossus, Marc Graille, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 8, 2003
Crystal structure of a hydrophobic immunodominant antigenic site on hepatitis C virus core protein complexed to monoclonal antibody 19D9D6Renée Ménez, Marc Bossus, Bruno H Muller, et al.Placenta|March 20, 2016
Expression patterns of ERVWE1/Syncytin-1 and other placentally expressed human endogenous retroviruses along the malignant transformation process of hydatidiform molesPierre-Adrien Bolze, Sophie Patrier, Valérie Cheynet, et al.Journal of Molecular Biology|October 25, 2011
In vitro affinity maturation of an anti-PSA antibody for prostate cancer diagnostic assayBruno H Muller, Alexandra Savatier, Guillaume L'Hostis, et al.Journal of Molecular Biology|October 26, 2005
Crystal structure of the complex between the monomeric form of Toxoplasma gondii surface antigen 1 (SAG1) and a monoclonal antibody that mimics the human immune responseMarc Graille, Enrico A Stura, Marc Bossus, et al.International Journal of Cancer|February 22, 2002
Lipopeptide-based melanoma cancer vaccine induced a strong MART-27-35-cytotoxic T lymphocyte response in a preclinal studyFrédérique-Anne Le Gal, Armelle Prevost-Blondel, Renée Lengagne, et al.Pageof 1